Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow disability progression.

Rundown 00:18 - Young Bucks Self-Burials 06:15 - Austin Theory/WWE Update 10:20 - John Cena Is A Coward 14:15 - Bret Hart BLASTS Gunther Get 76% off, four free months, and a free Amazon gift card when ...